# Gynecologic Oncology * **Definition:** A specialized field of medicine that focuses on the diagnosis, treatment, and management of cancers that affect the female reproductive system, including ovarian, uterine, cervical, vulvar, and vaginal cancers. * **Taxonomy:** Specialties / Gynecologic Oncology ## News * Selected news on the topic of **Gynecologic Oncology**, for healthcare technology leaders * 8.6K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**The specialty that feels most valued by employers**](https://www.beckershospitalreview.com/quality/hospital-physician-relationships/the-specialty-that-feels-most-valued-by-employers/) | [[Beckers Hospital Review]] | | 2/26/2025 | [**Impact of delayed cord clamping on respiratory distress in late preterm and early term infants ...**](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00058-6/fulltext) | [[The Lancet]] | | 2/13/2025 | [**Endometrial Cancer Disparities: Improving Black Women's Access to Care and Trials**](https://www.medscape.com/viewarticle/1001979) | [[Medscape]] | | 2/7/2025 | [**19 Mercy Medical Center in Baltimore Physicians Named Castle Connolly's "Top Doctors" for 2025**](https://www.prweb.com/releases/19-mercy-medical-center-in-baltimore-physicians-named-castle-connollys-top-doctors-for-2025-302371635.html) | [[PRWeb]] | | 12/26/2024 | [**Cosmos Health Appoints Dimitrios Trafalis as Head of Oncology - FirstWord Pharma**](https://firstwordpharma.com/story/5923956) | [[FirstWord PHARMA]] | | 12/16/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827918) | [[JAMA Network]] | | 12/14/2024 | [**ICYMI: Highlights From COA 2024**](https://www.ajmc.com/view/icymi-highlights-from-coa-2024) | [[AJMC]] | | 12/12/2024 | [**Health IT Business News - December 12, 2024**](https://www.healthitanswers.net/health-it-business-news-december-12-2024/) | [[Health IT Answers]] | | 12/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827395) | [[JAMA Network]] | | 11/15/2024 | [**Virtual Clinical Trials Market Projected to Reach USD 14.89 Billion by 2032 with a CAGR of 6.07 SNS Insider**](https://finance.yahoo.com/news/virtual-clinical-trials-market-projected-140000642.html) | [[Yahoo Finance]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.morningstar.com/news/business-wire/20241029349293/precision-medicine-global-thought-leader-dr-howard-mcleod-joins-cofactor-genomics-advisory-board-as-cofactor-brings-oncoprism-test-to-partnered-hospitals) | [[Morningstar]] | | 10/25/2024 | [**Interventional Radiology Products Market to grow by USD 5.45 Billion from 2024-2028, driven by rising demand for minimally invasive surgeries and AI-powered market transformation - Technavio**](https://www.prnewswire.com/news-releases/interventional-radiology-products-market-to-grow-by-usd-5-45-billion-from-2024-2028--driven-by-rising-demand-for-minimally-invasive-surgeries-and-ai-powered-market-transformation---technavio-302286467.html) | [[PR Newswire]] | | 10/22/2024 | [**HLTH: Avandra Launches World's Largest Federated Network for Medical Imaging and Clinical Data**](https://hitconsultant.net/2024/10/22/avandra-launches-worlds-largest-federated-network-for-medical-imaging-and-clinical-data/) | [[HIT Consultant]] | | 10/16/2024 | [**FDA strengthens AI regulation to ensure patient safety and innovation in healthcare**](https://www.news-medical.net/news/20241016/FDA-strengthens-AI-regulation-to-ensure-patient-safety-and-innovation-in-healthcare.aspx) | [[News Medical Net]] | | 10/9/2024 | [**Look Who's Talking at HLTH - MedCity News**](https://medcitynews.com/2024/10/look-whos-talking-at-hlth/) | [[MedCity News]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**Quantum Health Appoints Dr. Stanley Crittenden as New Chief Medical Officer**](http://www.businesswire.com/news/home/20240812304065/en/Quantum-Health-Appoints-Dr.-Stanley-Crittenden-as-New-Chief-Medical-Officer/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](http://www.businesswire.com/news/home/20240628892797/en/Genoks-and-Velsera-Forge-Strategic-Partnership-to-Revolutionize-Cancer-Diagnostics-in-Turkey/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **University of Texas MD Anderson Cancer Center**: A leading cancer center that partnered with the Union for International Cancer Control to enhance global efforts in addressing gynecologic cancers. - **Community Oncology Alliance (COA)**: An organization focused on addressing challenges in community oncology practices and advocating for better patient care. - **Olympus Corporation**: A medical technology company showcasing advanced gynecological products aimed at improving surgical performance and patient outcomes. - **Mount Sinai Health System**: A healthcare provider that launched the Center of Excellence for Gynecologic Cancer, focusing on advanced screening, diagnosis, and innovative treatments. - **Myriad Genetics, Inc.**: A genetics company focusing on oncology and women's health, investing in digital capabilities and innovative testing solutions. - **Dr. Gary B. Deutsch**: Chief of the Division of Surgical Oncology and director of the Robotic Surgical Oncology Program at NYU Langone Hospital, specializing in robotic and minimally invasive surgeries. - **Myriad Genetics**: A genetics company that integrated its MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform, streamlining genetic testing for gynecologic cancers. - **GE HealthCare**: A healthcare technology company involved in advancing personalized cancer care through innovative applications. - **Cofactor Genomics**: A clinical-stage diagnostics company aiming to bridge the precision medicine gap in oncology. - **Dr. Eve Cunningham**: Chief of Virtual Care and Digital Health at Providence, addressing challenges in managing electronic medical records (EMRs) in oncology. - **BridgeBio Oncology Therapeutics**: A biotechnology company focused on developing novel small molecule therapeutics targeting RAS and PI3K malignancies. - **Aspira Women's Health**: A company developing AI-driven diagnostics for women's health, including endometriosis detection. - **Genoks**: A Turkish genomics healthcare company partnering with Velsera to enhance cancer diagnostics and treatment. - **Gilead Sciences**: A biotechnology company known for its FDA-approved CAR T-cell therapies, including YESCARTA. - **University of Alberta Researchers**: Discovered the effectiveness of digoxin in treating dedifferentiated endometrial carcinoma (DDEC), a rare form of endometrial cancer. - **Bristol-Myers Squibb**: A major pharmaceutical company investing heavily in oncology research and development. - **Flatiron Health**: A company specializing in oncology-focused electronic health record software and real-world cancer data. - **Oracle**: Provider of electronic health record (EHR) solutions enhancing cancer care at Alfred Health through digitization and integration of clinical trial information. - **PAVmed Inc.**: A company focused on enhancing cancer care for underserved populations through its Veris Cancer Care Platform. ### Partnerships and Collaborations - **MD Anderson and UICC**: Collaboration to enhance global efforts in addressing breast and cervical cancer, including initiatives for women's cancers. - **Thera4Care**: A project aimed at enhancing theranostics use across Europe, focusing on various cancer types, including ovarian cancer. - **NYU Langone Hospital and Dr. Gary B. Deutsch**: Collaboration to enhance cancer patients' quality of life through innovative therapies and precise surgeries. - **Meaningful Insights Biotech Analytics and NCODA**: Collaboration to launch the Oncology Insights Program, providing actionable insights for oncology care. - **Genoks and Velsera**: Partnership to integrate Clinical Genomics Workspace into cancer diagnostic services for improved accuracy in cancer detection. - **N-Power Medicine and Merck Global Health Innovation Fund**: Funding to expand oncology clinics and enhance collaborations with biopharmaceutical companies. - **Aspira Women's Health and ARPA-H**: Funding received to develop an AI-driven blood test for detecting endometriosis. - **Myriad Genetics and GSK/QIAGEN**: Strategic partnerships to enhance capabilities in HRD diagnostic testing for cancer. - **Myriad Genetics and Flatiron Health**: Collaboration to integrate genetic testing into electronic medical records, improving access and workflow for clinicians. - **Trialbee and Inspire**: A partnership aimed at enhancing patient recruitment for clinical trials in oncology and rare diseases, utilizing Trialbee's Omnichannel Network. - **Flatiron Health and Lifebit Biotech**: Expanding collaboration into Japan to enhance cancer care through secure access to real-world data. - **Optic and Vindur Tx**: Partnership to utilize AI for discovering novel kinase inhibitors to improve cancer treatments. - **Flatiron Health and Lifebit Biotech Ltd**: Expanding collaboration into Japan to enhance cancer care through secure access to real-world data. - **Azra AI and various hospitals**: Utilizing AI-driven solutions to improve oncology care and streamline workflows across over 200 hospitals. - **QT Imaging Holdings and NXC Imaging**: Partnership to expand the Breast Acoustic CT Scanner technology for improved breast imaging. - **Velsera and Diagnostic Longwood**: This partnership aims to enhance NGS solutions in the Iberian market, integrating Velsera's Clinical Genomics Workspace with Diagnostic Longwood's distribution network. - **Labcorp and Ballad Health**: Strategic collaboration to improve laboratory services in the Appalachian Highlands. - **BioAI and Genomic Testing Cooperative**: Collaboration to improve biomarker discovery and diagnostics through AI. - **Viz.ai and Addario Lung Cancer Medical Institute**: Partnership aimed at enhancing early detection and treatment of lung cancer using AI. - **Keck School of Medicine and Ryght Research Network**: Collaboration to enhance clinical trial efficiency through AI technology. ### Innovations, Trends, and Initiatives - **Center of Excellence for Gynecologic Cancer**: Mount Sinai's initiative to combine innovative medical approaches with compassionate care, including clinical trials for new therapies. - **AI in Gynecologic Oncology**: The integration of AI technologies to enhance clinical decision-making, predictive analytics, and personalized treatment plans. - **CareIntellect for Oncology**: A cloud-based application by GE HealthCare that consolidates patient data for advanced insights into cancer treatment. - **Robotic Surgery**: Dr. Gary B. Deutsch's focus on robotic surgical oncology aims to improve surgical outcomes and patient recovery. - **Hyper-personalized Medicine**: An approach tailoring treatments based on genetic, environmental, and lifestyle factors, increasingly relevant in oncology. - **Theranostics**: An innovative approach combining imaging diagnostics with targeted therapeutics for personalized cancer care. - **Digoxin for DDEC**: Research indicating digoxin's potential as a treatment for dedifferentiated endometrial carcinoma, highlighting the need for new therapeutic options. - **AI-driven diagnostics**: Aspira Women's Health is developing AI-driven tests for endometriosis, building on previous successes in ovarian cancer diagnostics. - **Increased focus on precision medicine**: Efforts to enhance treatment options for patients with cancer, particularly those not responding to traditional therapies. - **AI in Oncology**: The integration of AI-driven solutions to enhance clinical decision-making and improve patient outcomes. - **CancerIQ Reach**: A new patient acquisition solution aimed at improving participation in cancer screenings and early diagnoses. - **Oracle EHR Implementation**: Transitioning from paper-based to digital records to enhance efficiency and quality of cancer care. - **Veris Cancer Care Platform**: Designed to offer personalized cancer care through remote data collection and telehealth capabilities. - **NewYork-Presbyterian's $2 Billion Campaign**: Aiming to advance technologies and digital transformation in oncology and cardiology. - **Liquid Biopsy**: Emerging as a non-invasive method for detecting cancer-related biomarkers, complementing traditional histology. - **AI-powered oncology workflow automation**: Azra AI is revolutionizing oncology care with a platform that analyzes pathology and radiology reports to expedite cancer diagnosis. ### Challenges and Concerns - **Disparities in Treatment Outcomes**: Minority patients with gynecologic cancers face significant disparities in survival outcomes despite receiving treatment at academic facilities. - **Data privacy and governance**: Ensuring secure access to oncology data while maintaining patient privacy in research collaborations. - **Technology Overload in Community Oncology**: Challenges in adopting new technologies due to limited resources and expertise, leading to fragmented systems. - **Healthcare Disparities**: Incarcerated women face significant barriers to cancer screenings and follow-ups, leading to preventable suffering. - **Clinical Trial Recruitment**: The ongoing challenge of recruiting suitable patients for clinical trials, particularly in oncology, necessitating innovative solutions. - **Shortage of Oncology Professionals**: Significant lack of trained oncologists and nurses in SAARC nations due to inadequate education and training. - **Reimbursement cuts for oncology providers**: Concerns raised at COA meetings regarding potential cuts due to drug price negotiations under the Inflation Reduction Act. - **Access to Theranostics**: Current limitations in access to theranostic treatments, primarily available in specialized centers. - **Adverse Effects of Treatments**: Concerns regarding the side effects of innovative cancer therapies, including CAR T-cell treatments. - **Need for Standardization**: There is an urgent need for the development of new radiotheranostics to broaden clinical applications and accessibility in cancer treatment. - **Access to Clinical Trials**: Challenges in matching patients to clinical trials and ensuring diverse representation in research. - **High Therapy Costs**: The cost of advanced cancer therapies remains a significant barrier to access for many patients. - **Burnout Among Clinicians**: Addressing clinician burnout is critical, as it impacts patient care and healthcare efficiency. - **Data Management in Healthcare**: The need for effective data utilization and management in clinical settings to enhance research capabilities and patient outcomes. - **Access to Care**: Older Americans, especially those with cognitive impairments, encounter barriers in accessing high-value clinical services, highlighting the need for improved management strategies. - **High Treatment Costs**: Despite advancements in diagnostics and treatments, high costs limit access to innovative therapies for many patients. - **Administrative burdens in clinical trials**: High staff turnover and administrative tasks leading to delays in patient enrollment and therapy delivery. - **Market Dynamics**: Challenges faced by companies like Flatiron Health in maintaining partnerships and sales due to ownership concerns. - **Data Overload in EMRs**: Healthcare providers struggle with managing vast amounts of data in electronic medical records, impacting patient care. ## Related Topics [[Gynecology]]; [[Surgical Oncology]]; [[Oncology]]; [[Ocular Oncology]]